Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical…
| Price | $4.00 |
|---|---|
| Market cap | $32.25M |
| Sector | Healthcare |
| Industry | Medical - Care Facilities |
| Exchange | AMEX |
| 52-week range | 2.72-5.01 |
| Beta | 0.55 |
Explore CCEL's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.